
Experimental gene-silencing therapy offers hope for hepatitis B cure
Chronic hepatitis B is a long-lasting condition caused by the hepatitis B virus (HBV) that affects about 240 million people worldwide. Current antiviral treatments are designed to keep the virus under control, but they are not a cure, and medications are usually taken indefinitely.








